Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — Phase 2 trials
Prefer to look first? Browse the live map without signing up.
17 open options
- TRIALPHASE2RECRUITING
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
THC-free CBD Oil · Placebo — 1 site
- TRIALPHASE2RECRUITING
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Donanemab · Placebo — 72 sites
- TRIALPHASE2NOT_YET_RECRUITING
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Psilocybin · Cognitive Training — 1 site
- TRIALPHASE2RECRUITING
N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
Nicotinamide Riboside (NR) · Palacebo — 2 sites
- TRIALPHASE2RECRUITING
Open-label Extension Study in Participants With Early Alzheimer's Disease
GSK4527226 — 33 sites
- TRIALPHASE2ENROLLING_BY_INVITATION
Neuroimaging Study
Tau PET scan — 2 sites
- TRIALPHASE2RECRUITING
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Foralumab TZLS-401 50 µg · Foralumab TZLS-401 100 µg — 1 site
- TRIALPHASE2RECRUITING
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
Placebo · Varenicline — 1 site
- TRIALPHASE2RECRUITING
Repurposing Siponimod for Alzheimer's Disease
Siponimod · Placebo — 1 site
- TRIALPHASE2RECRUITING
Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease
Recharge Behavioral Therapy · Traditional Educational/Resources Program — 1 site
- TRIALPHASE2ENROLLING_BY_INVITATION
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
ML-007C-MA — 8 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
NSC001 · Placebo — 10 sites
- TRIALPHASE1 / PHASE2RECRUITING
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
Metfomin — 1 site
- TRIALPHASE2NOT_YET_RECRUITING
Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease
RB-ADSC · Placebo
- TRIALPHASE1 / PHASE2RECRUITING
Stem Cell Therapy for Early Alzheimer's Disease
adMSC — 1 site
- TRIALPHASE2RECRUITING
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
ML-007C-MA · Placebo — 55 sites
- TRIALPHASE2RECRUITING
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
[18F]-FEOBV Radiotracer — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.